Premium
In response: Commentary on clinical significance of CYP 2C9‐status‐guided valproic acid therapy in children[1][Gielgens RCW, ]
Author(s) -
Monostory Katalin,
Bűdi Tamás,
Tóth Katalin,
Nagy Andrea,
Szever Zsuzsa,
Kiss Ádám,
Temesvári Manna,
Háfra Edit,
Tapodi Adrienn,
Garami Miklós
Publication year - 2016
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/epi.13451
Subject(s) - cyp2c9 , valproic acid , epilepsy , dosing , genotype , medicine , pharmacology , therapeutic index , mood stabilizer , genotyping , hyperammonemia , pharmacogenetics , cyp2d6 , gastroenterology , endocrinology , anticonvulsant , cytochrome p450 , metabolism , biology , drug , biochemistry , psychiatry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom